GL1X · GenesisL1 explorer

Research workbench

HIV-1 integrase catalytic core domain complexed with allosteric inhibitor (2S)-tert-BUTOXY[4-(4-chlorophenyl)-6-(3,4-dimethylphenyl)- 2,5-dimethylpyridin-3-YL]ETHANOIC acid

Analyse HIV-1 integrase catalytic core domain complexed with allosteric inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4O0J
Type
protein
Length
142 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
UniProt
P12497
Ligands
LF8, SO4

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegraseprotein14249% helix, 20% strandP12497

Ligands and binding sites

  • LF8 · (2S)-tert-butoxy[4-(4-chlorophenyl)-6-(3,4-dimethylphenyl)-2,5-dimethylpyridin-3-yl]ethanoic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Modifications

Observed in the structure: 2 modified (nonstandard).

Compared structures

  • 4O0J · HIV-1 Integrase Catalytic Core Domain Complexed with Allosteric Inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.